BGB-3111-309
Active, not recruiting
A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
BeOne Study ID
BGB-3111-309
ClinicalTrials.gov ID
EudraCT or EUCT Number
2022-501147-32-00
China Drug Trials ID
CTR20230546
Study Overview
Sex: All
Age: 18 Years / 75 Years
Accepts Healthy Volunteers? No
No Study Documents
Study Overview
Sex: All
Age: 18 Years / 75 Years
Accepts Healthy Volunteers? No
No Study Documents